Cadence has agreed to buy Arm’s physical IP unit Artisan including its engineering team, standard cell libraries, memory compilers, and general-purpose I/Os (GPIOs). Arm bought Artisan in 2004 for ...

This webinar will also explore: The FDA’s stance on synthetic control arms being used in clinical trials How synthetic control arms reduce patient recruitment in clinical trials Managing the ...

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations?

An inhalers and derma products manufacturing plant of Aurobindo Pharma subsidiary Aurolife Pharma LLC in the U.S. has been issued 11 observations by the United States Food and Drug Administration ...

The investigational device exemption trial enrolled 130 acute intermediate-risk pulmonary embolism patients across 22 US ...

This necessitated the development of an international evidence-based clinical guideline.14 Since the publication of this guideline, additional studies have been undertaken and published on this topic.

[JAKARTA] Indonesian President Prabowo Subianto said Qatar is set to invest US$2 billion in his country’s new sovereign wealth fund as he looks to boost economic growth. Prabowo is on a five-nation ...

Synthetic control arms use statistical methods to create a virtual control group based on observed data from a multitude of sources. Image credit: Shutterstock/Evdokimov Maxim. Amid the brighter ...

Public donations and clinical partnerships are helping us to make the discoveries that defeat cancer. We discovered that DNA damage is the basic cause of cancer, laying the foundation for the idea ...

The facility will adjoin the ED and offer streamlined diagnosis and improved care for patients requiring immediate life-saving intervention, as well as outpatient monitoring. The facility will adjoin ...

Falls: assessment and prevention in older people and in people 50 and over at higher risk NG249 29 April 2025 29 April 2025 ...